Covidien has reported double-digit net income results for the second quarter of fiscal 2012, which ended March 31.
Eckert & Ziegler has begun construction of a production facility for cyclotron-based PET radiopharmaceuticals in Warsaw, Poland.
GE Healthcare and NXT2B, a privately owned venture capital company started in 2011, have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and PET tracer production.
The Federal Trade Commission (FTC) is seeking public comment on an application by Cardinal Health, which is requesting approval to sell former Cardinal Health nuclear pharmacy assets to Patient Care Infusion.
Revelations about the actual cause of myocardial infarction have led researchers to seek out new ways to diagnose, evaluate, treat and prevent coronary artery disease, specifically through imaging vulnerable plaque.
The radiopharmaceutical, I-131-MIP-1466, which is designed to deliver a therapeutic dose of radiation to metastatic prostate cancer, will enter a clinical trial to evaluate its efficacy and benefits for patients.
The Texas Department of State Health Services-Radiation Control Program has granted Positron's wholly owned subsidiary, Manhattan Isotope Technology, approval of its radioactive materials license amendment.
Positron has acquired all of the assets and business operations and retained all employees of Manhattan Isotope Technology (MIT). In exchange, MIT will receive cash advances, assumption of certain indebtedness and earn-out consideration of $3.5 million, based on 20 percent of the net income from sales relating to radioisotope and radiopharmaceutical operations of MIT.
Positron has received a nuclear pharmacy license from the Indiana Board of Pharmacy for its Crown Point, Ind., manufacturing facility.
Positron, a molecular imaging company specializing in nuclear cardiology, has relocated its PosiRx manufacturing, product research and development facility. The new office is approximately three miles from its current Fishers, Ind., location.
PET imaging is showing a 7 percent average annual growth rate from 2008 to 2010, which is a decrease from the average annual rate of 10.4 percent from 2005 to 2008, according to IMV's research report, 2011 PET Market Summary Report.
Cardinal Health officially opened the $11 million Center for the Advancement of Molecular Imaging—a new, collaborative laboratory that will seek to develop nuclear imaging agents that treat complex diseases like cancer, heart disease and neurological disorders—in Phoenix on July 18.
Data from the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories suggest that while non-compliance with reporting standards is found in the majority of U.S. nuclear cardiology laboratories, facilities that participate in the accreditation process demonstrate an increase in compliance over time. The retrospective study was published online June 19 in the Journal of Nuclear Cardiology.
The U.S. market for SPECT and PET systems will increase nearly six-fold over the next seven years as new products are introduced to the market, according to a Bio-Tech Systems report.
In its June report to Congress, the Medicare Payment Advisory Commission (MedPAC) recommended reduced reimbursement, payment bundling and prior authorization for medical imaging services.
Cardinal Health has opened its first cyclotron facility in the state of Georgia, expanding its capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological disorders and heart disease.
Positron, a nuclear cardiology company, has executed a memorandum of understanding with the City of Noblesville, Ind., to relocate its corporate headquarters, research & development and product manufacturing facilities to Noblesville.
For nearly 40 years, residents have had to decide between one of two tracks for nuclear medicine training, a fragmented and outdated system that, thanks to shifts toward healthcare reform and molecular imaging, must be reconciled, according to a joint Society of Nuclear Medicine (SNM) and American College of Radiology (ACR) task force article published in the June issue of The Journal of Nuclear Medicine.
Cardinal Health is launching the Center for the Advancement of Molecular Imaging, its new laboratory, which it plans to open in July 2011. The company is previewing the new center at this week's SNM annual meeting in San Antonio, Texas.
Thomas Tulip, PhD, has joined radiopharmaceutical developer Neoprobe as executive vice president and chief business officer.
|
RSS 
